AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Berruti, A Dogliotti, L Mosca, A Gorzegno, G Bollito, E Mari, M Tarabuzzi, R Poggio, M Torta, M Fontana, D Angeli, A
Citation: A. Berruti et al., Potential clinical value of circulating chromogranin A in patients with prostate carcinoma, ANN ONCOL, 12, 2001, pp. S153-S157

Authors: Bollito, E Berruti, A Bellina, A Mosca, A Leonardo, E Tarabuzzi, R Cappia, S Mari, M Tampellini, M Fontana, D Gubetta, L Angeli, A Dogliotti, L
Citation: E. Bollito et al., Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma, ANN ONCOL, 12, 2001, pp. S159-S164

Authors: Berruti, A Dogliotti, L Mosca, A Tarabuzzi, R Torta, M Mari, M Gorzegno, G Fontana, D Angeli, A
Citation: A. Berruti et al., Effects of the somatostatin analog lanreotide on the circulating levels ofchromogranin-A, prostate-specific antigen, and insulin-like growth factor-I in advanced prostate cancer patients, PROSTATE, 47(3), 2001, pp. 205-211

Authors: Berruti, A Dogliotti, L Tucci, M Tarabuzzi, R Fontana, D Angeli, A
Citation: A. Berruti et al., Metabolic bone disease induced by prostate cancer: Rationale for the use of bisphosphonates, J UROL, 166(6), 2001, pp. 2023-2031

Authors: Porpiglia, F Destefanis, P Fiori, C Tarabuzzi, R Fontana, D
Citation: F. Porpiglia et al., Laparoscopic diagnosis and management of acute intra-abdominal testicular torsion, J UROL, 166(2), 2001, pp. 600-601

Authors: Berruti, A Dogliotti, L Mosca, A Bellina, M Mari, M Torta, M Tarabuzzi, R Bollito, E Fontana, D Angeli, A
Citation: A. Berruti et al., Circulating neuroendocrine markers in patients with prostate carcinoma, CANCER, 88(11), 2000, pp. 2590-2597

Authors: Berruti, A Dogliotti, L Fasolis, G Mosca, A Tarabuzzi, R Torta, M Mari, M Fontana, D Angeli, A
Citation: A. Berruti et al., Changes in free and free-to-total prostate specific antigen after androgendeprivation or chemotherapy in patients with advanced prostate cancer, J UROL, 161(1), 1999, pp. 176-181
Risultati: 1-7 |